Efficacy of neck treatment in patients with head and neck squamous cell carcinoma

被引:15
|
作者
Buck, Gabriela [2 ]
Huguenin, Pia [1 ,3 ]
Stoeckli, Sandro J.
机构
[1] Univ Zurich Hosp, Clin Otorhinolaryngol Head & Neck Surg, CH-8091 Zurich, Switzerland
[2] Spital Zollikerberg, Dept Internal Med, Zollikerberg, Switzerland
[3] Rat Kantons & Regionalspital, Dept Radiat Oncol, Chur, Switzerland
关键词
neck dissection; head and neck squamous cell carcinoma; adjuvant radiation; neck treatment; lymph node metastasis;
D O I
10.1002/hed.20657
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. Treatment of head and neck squamous cell carcinoma (HNSCC) addresses the primary tumor and the lymphatic drainage. Modalities for the neck are neck dissection and/or radiation therapy. In most cases, the neck is treated by the modality that seems more appropriate for the primary. The aim of this study was to analyze the results of the neck treatments either by neck dissection alone, by radiation therapy alone or by neck dissection followed by radiation therapy. Methods. This was a retrospective chart analysis of 699 patients treated for a previously untreated HNSCC. The primary endpoint was recurrence at the treated neck. Results. Two hundred eighty-one (40%) patients underwent primary neck irradiation, 219 (31%) neck dissection alone, and 199 (29%) neck dissection followed by adjuvant irradiation. The 5-year regional control rates after neck dissection alone were 83% for pNO, 75% for pN1, 60% for pN2a, 59% for pN2b, and 50% for pN2c; after radiation alone. 89% for cNO, 87% for cN1, 40% for cN2a, 60% for cN2b, and 48% for cN2c; and after neck dissection with adjuvant radiation, 86% for pNO, 96% for pN1, 100% for pN2a, 88% for pN2b, and 88% for pN2c. Conclusions. Radiation or neck dissection alone are efficient to control early neck disease. For advanced N2/3 neck disease, neck dissection followed by adjuvant radiation is highly efficient, whereas primary radiation results in a high number of regional failures. The literature suggests planned neck dissection to improve regional control for these patients. (c) 2007 Wiley Periodicals, Inc.
引用
收藏
页码:50 / 57
页数:8
相关论文
共 50 条
  • [1] TREATMENT OF NECK IN PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF HEAD AND NECK
    JESSE, RH
    FLETCHER, GH
    CANCER, 1977, 39 (02) : 868 - 872
  • [2] Treatment of elderly Patients with Squamous Cell Carcinoma of the Head and Neck
    Szturz, Petr
    Vermorken, Jan B.
    FRONTIERS IN ONCOLOGY, 2016, 6
  • [3] Selective neck dissection in the treatment of head and neck squamous cell carcinoma patients with a clinically positive neck
    Lopez, Fernando
    Fernandez-Vanes, Laura
    Garcia-Cabo, Patricia
    Grilli, Gianluigi
    Alvarez-Marcos, Cesar
    Luis Llorente, Jose
    Pablo Rodrigo, Juan
    ORAL ONCOLOGY, 2020, 102
  • [4] Efficacy of gemcitabine and cetuximab combination treatment in head and neck squamous cell carcinoma
    Maseki, Shinichiro
    Ijichi, Kei
    Nakanishi, Hayao
    Hasegawa, Yasuhisa
    Ogawa, Tetsuya
    Murakami, Shingo
    MOLECULAR AND CLINICAL ONCOLOGY, 2013, 1 (05) : 918 - 924
  • [5] Cetuximab in the treatment of squamous cell carcinoma of the head and neck
    Specenier, Pol
    Vermorken, Jan B.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (04) : 511 - 524
  • [6] Afatinib in the treatment of head and neck squamous cell carcinoma
    Ferrarotto, Renata
    Gold, Kathryn A.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (01) : 135 - 143
  • [7] Taxanes in the Treatment of Head and Neck Squamous Cell Carcinoma
    Hsieh, Ching-Yun
    Lin, Ching-Chan
    Chang, Wei-Chao
    BIOMEDICINES, 2023, 11 (11)
  • [8] Systemic Treatment for Squamous Cell Carcinoma of the Head and Neck
    Shetty, Aditya V.
    Wong, Deborah J.
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2017, 50 (04) : 775 - +
  • [9] Efficacy of Multimodality Approach in Patients With Recurrent Head and Neck Squamous Cell Carcinoma
    Hoell, Pascale Alicia
    Elsayad, Khaled
    Berssenbruegge, Hendrik
    Hering, Dominik
    Kittel, Christopher
    Kleinheinz, Johannes
    Bleckmann, Annalen
    Evers, Georg
    Wardelmann, Eva
    Rudack, Claudia
    Eich, Hans Theodor
    ANTICANCER RESEARCH, 2023, 43 (03) : 1255 - 1263
  • [10] Oligometastases in head and neck squamous cell carcinoma patients
    de Bree, Remco
    Hardillo, Jose A.
    de Ridder, Mischa
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (01) : 1 - 3